drugset
Drugs / Vi-DT typhoid conjugate vaccine
last change Jan 2021 re-read 9 days ago

Vi-DT typhoid conjugate vaccine

also known as Vi-DT

Vaccine

Developed for
typhoid fever
Investigated by
Bill and Melinda Gates Foundation · International Vaccine Institute · SK Bioscience Co., Ltd.

Trials 1

today NCT03527355 · Ph 2
201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03527355 Apr → Jul 2018 typhoid fever International Vaccine Institute Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Vi-DT typhoid conjugate vaccine “Vi-DT typhoid conjugate vaccine” NCT03527355 ↗
Known as Vi-DT ClinicalTrials.gov intervention name — accepted as the source's own label NCT03527355 ↗
Modality Vaccine “we investigated the safety, immunogenicity and dose-scheduling of Vi-DT typhoid conjugate vaccine among children aged 6-23 months.” PMID 33150320 ↗ Sep 2020